Synapse - Ashley Regazzi

Search Within

Ashley Regazzi

Results (93)

Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)

Meeting Abstract

Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents

Journal Article

Tully, C. M.; Apolo, A. B.; Zabor, E. C.; Regazzi, A. M.; Ostrovnaya, I.; Furberg, H. F.; Rosenberg, J. E.; Bajorin, D. F.
Cancer (2016)

Fulltext@MSK | Save

Externally validated improved 5-factor prognostic model in patients (pts) receiving salvage systemic therapy for advanced urothelial carcinoma (UC)

Meeting Abstract

Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Mullane, S. A.; Niegisch, G.; Albers, P.; Necchi, A.; di Lorenzo, G.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Improved prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

Meeting Abstract

Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Mullane, S. A.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Split-dose cisplatin as an alternative to every-3-week dosing when using cisplatin/gemcitabine to treat advanced urothelial

Meeting Abstract

Gonzalez, C. M.; Jordan, E.; Zabor, E. C.; Kania, B. E.; Regazzi, A. M.; Ostrovnaya, I.; Iyer, G.; Bajorin, D. F.; Bambury, R. M.; Rosenberg, J. E.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer

Meeting Abstract

Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; Bajorin, D. F.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: A large single-institution experience

Journal Article

Bambury, R. M.; Benjamin, D. J.; Chaim, J. L.; Zabor, E. C.; Sullivan, J.; Garcia-Grossman, I. R.; Regazzi, A. M.; Ostrovnaya, I.; Apollo, A.; Xiao, H.; more...
The Oncologist (2015)

Fulltext@MSK | Save

Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma

Journal Article

Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Clinical Genitourinary Cancer (2015)

Fulltext@MSK | Save

Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: Implications for trial design

Journal Article

Pond, G. R.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Clinical Genitourinary Cancer (2015)

Fulltext@MSK | Save

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma (UC) based on the impact of prognostic factors

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save